Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Your confirmation email is on its way. Please check your inbox for further instructions.

Acuitas Investments LLC Boosts Holdings in Arteris, Inc. (NASDAQ:AIP)

Acuitas Investments LLC raised its position in Arteris, Inc. (NASDAQ:AIP - Free Report) by 150.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 215,991 shares of the company's stock after acquiring an additional 129,692 shares during the period. Acuitas Investments LLC owned approximately 0.59% of Arteris worth $1,272,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of AIP. Ibex Investors LLC acquired a new stake in shares of Arteris during the third quarter worth $99,000. Barclays PLC acquired a new stake in shares of Arteris during the third quarter worth $120,000. Algert Global LLC acquired a new stake in shares of Arteris during the third quarter worth $142,000. Worth Venture Partners LLC lifted its stake in shares of Arteris by 22.6% during the third quarter. Worth Venture Partners LLC now owns 51,301 shares of the company's stock worth $334,000 after buying an additional 9,448 shares during the period. Finally, Citigroup Inc. acquired a new stake in shares of Arteris during the third quarter worth $363,000. 64.36% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Arteris

In other Arteris news, VP Paul L. Alpern sold 11,250 shares of Arteris stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $6.13, for a total value of $68,962.50. Following the completion of the transaction, the vice president now owns 87,521 shares of the company's stock, valued at $536,503.73. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, VP Paul L. Alpern sold 11,250 shares of the business's stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $6.13, for a total transaction of $68,962.50. Following the completion of the sale, the vice president now owns 87,521 shares of the company's stock, valued at $536,503.73. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Laurent R. Moll sold 4,191 shares of the business's stock in a transaction dated Tuesday, April 2nd. The stock was sold at an average price of $7.03, for a total transaction of $29,462.73. Following the sale, the chief operating officer now directly owns 588,887 shares of the company's stock, valued at approximately $4,139,875.61. The disclosure for this sale can be found here. Over the last quarter, insiders sold 80,264 shares of company stock valued at $558,958. Corporate insiders own 36.10% of the company's stock.


Wall Street Analyst Weigh In

Separately, Wedbush reiterated an "outperform" rating and set a $17.00 price objective on shares of Arteris in a research note on Tuesday, February 20th.

Get Our Latest Report on Arteris

Arteris Stock Performance

NASDAQ AIP traded down $0.06 on Friday, reaching $6.70. 81,742 shares of the company's stock traded hands, compared to its average volume of 141,324. The firm has a market cap of $257.08 million, a price-to-earnings ratio of -6.44 and a beta of 1.03. The stock has a 50 day moving average price of $6.97 and a 200-day moving average price of $6.16. Arteris, Inc. has a fifty-two week low of $3.66 and a fifty-two week high of $8.08. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.26 and a current ratio of 1.26.

Arteris (NASDAQ:AIP - Get Free Report) last posted its earnings results on Tuesday, February 20th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.27) by ($0.01). Arteris had a negative net margin of 68.70% and a negative return on equity of 150.71%. The business had revenue of $12.50 million for the quarter, compared to analyst estimates of $11.90 million. Equities research analysts predict that Arteris, Inc. will post -0.9 EPS for the current fiscal year.

Arteris Company Profile

(Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Featured Articles

Institutional Ownership by Quarter for Arteris (NASDAQ:AIP)

Should you invest $1,000 in Arteris right now?

Before you consider Arteris, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.

While Arteris currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Featured Articles and Offers

4 Downgraded Stocks Still Worth a Look

4 Downgraded Stocks Still Worth a Look

Despite recent analyst downgrades, these stocks might offer golden opportunities to buy on a dip.

Search Headlines: